Abstract
Colchicine is used for patients with primary biliary cirrhosis due to its immunomodulatory and antifibrotic potential. The results from randomized clinical trials have, however, been inconsistent. We conducted a systematical review to evaluate the effect of colchicine for primary biliary cirrhosis.
Originalsprog | Engelsk |
---|---|
Tidsskrift | American Journal of Gastroenterology |
Vol/bind | 100 |
Udgave nummer | 8 |
Sider (fra-til) | 1876-85 |
Antal sider | 10 |
ISSN | 0002-9270 |
DOI | |
Status | Udgivet - aug. 2005 |